184 related articles for article (PubMed ID: 35335935)
1. Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients.
Cura Y; Sánchez-Martín A; Márquez-Pete N; González-Flores E; Martínez-Martínez F; Pérez-Ramírez C; Jiménez-Morales A
Pharmaceutics; 2023 Oct; 15(11):. PubMed ID: 38004528
[TBL] [Abstract][Full Text] [Related]
2. CircRNA: a rising star in leukemia.
Li Q; Ren X; Wang Y; Xin X
PeerJ; 2023; 11():e15577. PubMed ID: 37431465
[TBL] [Abstract][Full Text] [Related]
3. Association Studies in Clinical Pharmacogenetics.
Zubiaur P; Abad-Santos F
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678742
[TBL] [Abstract][Full Text] [Related]
4. Formulation, Optimization and Evaluation of Cytarabine-Loaded Iron Oxide Nanoparticles: From In Vitro to In Vivo Evaluation of Anticancer Activity.
Fule R; Kaleem M; Asar TO; Rashid MA; Shaik RA; Eid BG; Nasrullah MZ; Ahmad A; Kazmi I
Nanomaterials (Basel); 2022 Dec; 13(1):. PubMed ID: 36616087
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of ABCB1, CDA, DCK, GSTT1, GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia.
Yunis LK; Linares-Ballesteros A; Aponte N; Barros G; García J; Niño L; Uribe G; Quintero E; Yunis JJ
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1744. PubMed ID: 36316809
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.
Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Poveda JL; Montesinos P
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456712
[TBL] [Abstract][Full Text] [Related]
7. Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
Derman BA; Larson RA
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101102. PubMed ID: 31779969
[TBL] [Abstract][Full Text] [Related]
8. Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives.
Pinto-Merino Á; Labrador J; Zubiaur P; Alcaraz R; Herrero MJ; Montesinos P; Abad-Santos F; Saiz-Rodríguez M
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335935
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics and the treatment of acute myeloid leukemia.
Megías-Vericat JE; Montesinos P; Herrero MJ; Bosó V; Martínez-Cuadrón D; Poveda JL; Sanz MÁ; Aliño SF
Pharmacogenomics; 2016 Jul; 17(11):1245-1272. PubMed ID: 27381050
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.
Kantarjian HM; Kadia TM; DiNardo CD; Welch MA; Ravandi F
Cancer; 2021 Apr; 127(8):1186-1207. PubMed ID: 33734442
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia.
Megias-Vericat JE; Martinez-Cuadron D; Herrero MJ; Alino SF; Poveda JL; Sanz MA; Montesinos P
Curr Drug Metab; 2018; 19(1):55-74. PubMed ID: 29090664
[TBL] [Abstract][Full Text] [Related]
12. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
